A Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of ConvitVax in Metastatic Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: BIOLOGICAL: ConvitVax
Sponsor: Jacinto Convit World Organization Inc.
Collaborators: Fundación Jacinto Convit|Instituto Oncologico Luis Razetti